Symbiotec Pharmalab Pvt Ltd
Healthcare
Symbiotec eyes IPO to give exit to PE investors; can it command a high valuation?
Bulk drug maker Symbiotec Pharmalab is planning to explore the possibility of floating an initial public offering in the next ......
Healthcare
Bottomline: InvAscent-backed Symbiotec has struggled to break out; will FY25 be different?
Homegrown corticosteroid and hormones API-maker Symbiotec Lifesciences Pvt. Ltd’s revenue and profitability took a hit in FY23, even as the ......
Healthcare
Why Indian bulk-drug makers are attracting greater investor interest
Private equity investors as well as pharmaceutical companies are showing higher interest in the bulk-drugs segment in India, industry executives ......
Healthcare
Motilal Oswal PE-InvAscent consortium buys out Actis from Symbiotec
A consortium of mid-market private equity firms InvAscent and Motilal Oswal PE has bought British PE firm Actis' entire stake ......
Healthcare
Mid-market PE consortium in talks to buy Actis' stake in Symbiotec
Actis Advisers Pvt. Ltd is in the final stages of negotiations with a consortium of fellow private equity firms to ......
Healthcare
Symbiotec Pharmalab gets interest from new set of PE firms
Symbiotec Pharmalab Pvt. Ltd has attracted interest from a new set of global private equity investors, as majority owner Actis ......
Healthcare
Actis in talks with marquee PE firms, pharma co to sell Symbiotec stake
Private equity (PE) firm Actis Advisers Pvt. Ltd. has engaged an investment bank for the sale of its majority stake ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News